Import alert · FDA Import Alerts (Industry 54)

Changchun GeneScience Pharmaceutical Co., Ltd.: FDA Import Alert 66-71 (Aug 9, 2017)

Agency action: Aug 9, 2017Record ID: 66-71|Changchun GeneScience Pharmaceutical Co., Ltd.|2017-08-09
View official source ↗

What happened

Original notice title

"Detention Without Physical Examination of Unapproved Human Growth Hormone (HGH)"

From the archived source record

"Detention Without Physical Examination of Unapproved Human Growth Hormone (HGH)". Firm/address: Changchun GeneScience Pharmaceutical Co., Ltd. Date Published : 08/09/2017 No. 72 Tianhe Street , Changchun High-Tech Dev. Zone , Changchun City, Jilin CHINA

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Active/current Red List snapshot
Source checked
Jul 16, 2026
Record revision
82f95621f087

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Human Growth Hormone (HGH); Somapacitan-beco; Somatropin
Company
Changchun GeneScience Pharmaceutical Co., Ltd.
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.